Quality of life (QoL) and symptoms in transfusion-dependent patients with myelodysplastic syndromes (MDS) undergoing oral chelation therapy

被引：0
|
作者：
Efficace, Fabio [1 ]
Cottone, Francesco [1 ]
Vignetti, Marco [2 ]
Mandelli, Franco [1 ]
Angelucci, Emanuele [3 ]
机构：
[1] GIMEMA, Italian Grp Adult Hematol Dis, Rome, Italy
[2] GIMEMA Data Ctr, Hlth Outcomes Res Unit, Rome, Italy
[3] Osped Oncol Riferimento Reg A Businco, Rome, Italy
来源：
QUALITY OF LIFE RESEARCH | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
3092
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Do ESAs Reduce Transfusion Need among Transfusion-Dependent Myelodysplastic Syndromes (MDS) Patients?
    Smith, Sheila R. Weiss
    Sato, Masayo
    Baer, Maria R.
    Ke, Xuehua
    Gore, Steven D.
    Davidoff, Amy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S282 - S283
  • [12] Deferasirox (Exjade®) Is Effective and Well Tolerated in Chelation-Naive and Previously Chelated Patients with Transfusion-Dependent Myelodysplastic Syndromes (MDS)
    Schmid, Mathias
    Guerci-Bresler, Agnes
    Della Porta, Matteo
    Taylor, Kerry
    Habr, Dany
    Domokos, Gabor
    Roubert, Bernard
    Rose, Christian
    Gattermann, Norbert
    BLOOD, 2009, 114 (22) : 1464 - 1464
  • [13] Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
    Gattermann, Norbert
    Finelli, Carlo
    Della Porta, Matteo
    Fenaux, Pierre
    Stadler, Michael
    Guerci-Bresler, Agnes
    Schmid, Mathias
    Taylor, Kerry
    Vassilieff, Dominique
    Habr, Dany
    Marcellari, Andrea
    Roubert, Bernard
    Rose, Christian
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (09): : 1364 - 1371
  • [14] IRON CHELATION THERAPY IN TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE STUDY OF 53 PATIENTS IN A SINGLE INSTITUTION
    Finelli, C.
    Clissa, C.
    Barraco, M.
    De Maio, C.
    Fogli, M.
    Stanzani, M.
    Parisi, S.
    Paolini, S.
    Bosi, C.
    Cavo, M.
    HAEMATOLOGICA, 2017, 102 : 57 - 57
  • [15] RATIONALE FOR THERAPY DISCONTINUATION IN PATIENTS WITH LOWER-RISK TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROMES (LR-MDS)
    Gerds, A. T.
    Gupta, S.
    Sekeres, M. A.
    Nazha, A.
    Carraway, H. E.
    Hawthorne, S.
    King-Concialdi, K.
    McGuire, M.
    LEUKEMIA RESEARCH, 2017, 55 : S140 - S141
  • [16] Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes
    Lucijanic, Marko
    Lovrinov, Miran
    Skelin, Marko
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (07) : 595 - 595
  • [17] Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes
    Roy, Noemi B. A.
    Myerson, Saul
    Schuh, Anna H.
    Bignell, Patricia
    Patel, Roger
    Wainscoat, Jim S.
    McGowan, Simon
    Marchi, Emanuele
    Atoyebi, Wale
    Littlewood, Tim
    Chacko, Joseph
    Vyas, Paresh
    Killick, Sally B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (04) : 521 - 524
  • [18] Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes
    Delforge, Michel
    Selleslag, Dominik
    Beguin, Yves
    Triffet, Agnes
    Mineur, Philippe
    Theunissen, Koen
    Graux, Carlos
    Trullemans, Fabienne
    Boulet, Dominique
    Van Eygen, Koen
    Noens, Lucien
    Van Steenweghen, Steven
    Lemmens, Jan
    Pierre, Pascal
    D'hondt, Randal
    Ferrant, Augustin
    Deeren, Dries
    Van De Velde, Ann
    Wynendaele, Wim
    Andre, Marc
    De Bock, Robrecht
    Efira, Andre
    Breems, Dimitri
    Deweweire, Anne
    Geldhof, Kurt
    Pluymers, Wim
    Harrington, Amanda
    MacDonald, Karen
    Abraham, Ivo
    Ravoet, Christophe
    LEUKEMIA RESEARCH, 2014, 38 (05) : 557 - 563
  • [19] LEVELS OF TRANSFUSION BURDEN AND ASSOCIATED COSTS FOR PATIENTS WITH TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROMES
    DeZern, A. E.
    Binder, G.
    Rizvi, S.
    Corvino, F. A.
    Arikian, S. R.
    Surinach, A.
    Lee, J.
    Smith, B. D.
    HAEMATOLOGICA, 2016, 101 : 245 - 245
  • [20] Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion-dependent patients with myelodysplastic syndromes
    Piciocchi, Alfonso
    Sargentini, Valeria
    Cotugno, Francesca
    Bontempi, Katia
    Beltrami, Germana
    Di Tucci, Anna Angela
    Riva, Marta
    Quaresmini, Giulia
    Vallisa, Daniele
    Finelli, Carlo
    Borin, Lorenza
    Fazi, Paola
    Vignetti, Marco
    Angelucci, Emanuele
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (05) : 442 - 443
12345